Novartis AG ADR
NYSE: NVS
$103.54
-$0.74 (-0.7%)
Closing Price on November 25, 2024
NVS Articles
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is large cap pharmaceuticals. Here are their top large cap pharmaceuticals to buy now.
Published:
These are the top analyst upgrades, downgrades and initiations from Wall Street for Friday, May 2, 2014. They include Avanir, Avon, Broadcom, LinkedIn, Oracle and Wynn Resorts.
Published:
Mediwound offered 5 million shares in a Thursday IPO at the low end of the expected range. Akebia Therapeutics offered 5.9 million shares in its IPO at the high end of the expected price range....
Published:
Last Updated:
Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer immunotherapy...
Published:
ThinkstockSpeculation has run hot that Swiss drugmaker Novartis A.G. (NYSE: NVS) would announced further restructuring at its investor day in London. Instead, on Friday the company announced a $5...
Published:
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company...
Published:
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top...
Published:
Last Updated:
ThinkstockWith yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact of higher rates on stocks continues to be top of mind for investors. The...
Published:
Last Updated:
ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
Last Updated:
ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they...
Published:
Last Updated:
courtesy of AppleIn its third annual ranking of the world’s most innovative companies, analysts at Booz & Co. created two lists: one based on dollars spent and the other based on asking those...
Published:
A new consumer agency fines Capital One (NYSE: COF) $210 million for aggressive marketing activity.(Reuters) New IMF policies will examine whether individual national economies might hurt global...
Published:
The CEO of Chrysler said he took no pay in 2011 and that, based on financial results, the company is now worth $7.5 billion. (Reuters) The Treasury will sell $6 billion of AIG (NYSE: AIG) stock to...
Published:
The public and the press usually measure unemployment one month at a time as data from ADP and the federal government are issued. The jobs market can also be tracked in another way. Mass layoffs...
Published: